Globus Medical names new SVP of international and corporate programs
In this role, Mr Kenney will be responsible for all international operations driving growth with the full line of fusion and non-fusion products that have fueled Globus’s growth
Voro Therapeutics and Alloy Therapeutics have formed a strategic research partnership to develop tumour-selective, next-generation masked T-cell engager (TCE) therapeutics.
As a result, the Court ruled in part that: 1) Diagnostica Stago must cease manufacturing and selling its infringing products, STA-Staclot APC-R kits and STAGEN Kit FVM Mutation,